| Analyzed group (n=92) | MTWA (+) (n = 18) | MTWA (ind) (n = 18) | MTWA (−) (n = 56) | MTWA (non-) (n = 36) | MTWA(+) vs MTWA(−) p | MTWA(non-) vs MTWA(−) p |
---|---|---|---|---|---|---|---|
Males (%) | 40 (43.5) | 13 (72.2) | 8 (44.4) | 19 (33.9) | 21 (58.3) | 0.006 | 0.031 |
Age (years) | 29 | 28 | 31,5 | 29 | 29.5 | 0.782 | 0.620 |
Median | (18–75) | (19–64) | (20–75) | (18–74) | (19–22) |  |  |
Min-max | Â | Â | Â | Â | Â | Â | Â |
Operated (%) | 28 (27.5) | 9 (50) | 4 (22.2) | 9 (50) | 13 (36.1) | 0.786 | 0.663 |
NYHA | 1.0 | 2.0 | 2.0 | 1.0 | 2.0 | 0.231 | 0.040 |
Median | (1.0-3.0) | (1.0-3.0) | (1.0-3.0) | (1.0-3.0) | (1.0-3.0) | Â | Â |
Min-max | Â | Â | Â | Â | Â | Â | Â |
SO 2 (%) | 97 | 96 | 92.5 | 97 | 94.5 | 0.151 | 0.047 |
Median | (69–100) | (75–99) | (73–99) | (69–100) | (73–100) |  |  |
Min-max | Â | Â | Â | Â | Â | Â | Â |
Pulmonary hypertension (%) | 11 (12.0) | 1 (5.6) | 7 (38.9) | 9 (16.1) | 2 (5.6) | 0.434 | 0.191 |
Beta blocker (%) | 25 (27.1) | 7 (38.9) | 3 (16.7) | 15 (26.8) | 10 (27.8) | 0.380 | 1.0 |
QRS (ms) | 120 | 120 | 135 | 120 | 125 | 0.354 | 0.123 |
Median Min-max | (80–200) | (100–200) | (100–180) | (80–200) | (100–200) |  |  |